Trauma to the Central Nervous System (CNS) initiates a cascade of physiologic and molecular events that culminate in cellular injury and damage. Recent studies indicate that cells respond to trauma and other insults by altering the expression of specific genes. Among the genes expressed following CNS trauma are the immediate early genes (IEGs), many of which encode transcription factors. A second group of genes induced by CNS injury are those encoding heat-shock proteins (HSPs). Although the expression of these genes may be involved in the attempted recovery of function following brain trauma, little is known about the identity of the genes induced by trauma or the temporal/anatomic relationship between this induction and traumatic injury. Moreover, the consequences of post-traumatic induction of IEGs and HSPs remains poorly defined. This study will use molecular biology techniques to identify key changes in gene expression following experimental brain injury and relate these changes to histologic injury. Using in situ hybridization and immunohistochemistry, we will determine the timecourse and regional expression of several IEGs (c-fos, c-jun, junB, zif-268) in several models of brain trauma. We will then determine whether trauma-induced expression of IEGs is followed by expression of critical target genes, including proenkephalin, brain-derived neurotropic factor (BDNF), calbindin-D28K, and microtubule-associated protein (MAP2). We will also determine the timecourse and regional expression of hsp72, hsp90, and hsp32 (heme-oxygenase) following brain injury. Finally, we will correlate changes in gene expression with indicators of cell injury, including cellular calcium staining, blood-brain-barrier function, histologic damage and immunocytochemistry for glutamic acid decarboxylase (GAD). These studies will enhance our understanding of the cellular and molecular events following trauma and may lead to the development of novel targeted therapies for the treatment of traumatic brain injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS008803-26
Application #
6243407
Study Section
Project Start
1997-08-01
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
26
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nariai, Hiroki; Duberstein, Susan; Shinnar, Shlomo (2018) Treatment of Epileptic Encephalopathies: Current State of the Art. J Child Neurol 33:41-54
Nariai, Hiroki; Beal, Jules; Galanopoulou, Aristea S et al. (2017) Scalp EEG Ictal gamma and beta activity during infantile spasms: Evidence of focality. Epilepsia 58:882-892
Tomasevic, Gregor; Laurer, Helmut L; Mattiasson, Gustav et al. (2012) Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA. J Neurosurg 116:1368-78
Browne, Kevin D; Chen, Xiao-Han; Meaney, David F et al. (2011) Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 28:1747-55
Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe et al. (2010) Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 88:3414-23
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Marklund, N; Morales, D; Clausen, F et al. (2009) Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 163:540-51
Marklund, Niklas; Bareyre, Florence M; Royo, Nicolas C et al. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107:844-53
Keck, Carrie A; Thompson, Hilaire J; Pitkanen, Asla et al. (2007) The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci 25:77-90
Serbest, Gulyeter; Burkhardt, Matthew F; Siman, Robert et al. (2007) Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem Res 32:2006-14

Showing the most recent 10 out of 71 publications